Showing results (131-140 of 156) with videos related to
Sort By:
Pageof 16
Journal of Virology|March 13, 2009
Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivoSusan L Pichla-Gollon, Shih-Wen Lin, Scott E Hensley, et al.Journal of Medicinal Chemistry|November 8, 2021
N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding ConstantsAdam Konieczny, Marcus Conrad, Fabian J Ertl, et al.The Journal of Infectious Diseases|November 17, 2006
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138Michael M Lederman, Laura Smeaton, Kim Y Smith, et al.Journal of Virology|April 13, 2007
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectorsKimberly McCoy, Nia Tatsis, Birgit Korioth-Schmitz, et al.Plos One|January 5, 2011
Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionalityNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.Blood|January 18, 2013
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cellsAshley T Martino, Etiena Basner-Tschakarjan, David M Markusic, et al.Journal of Leukocyte Biology|December 29, 2012
Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaquesRaj Kurupati, Steve Tuyishime, Andrew V Kossenkov, et al.Plastic and Reconstructive Surgery. Global Open|August 18, 2020
Benchmarking Residual Limb Pain and Phantom Limb Pain in Amputees through a Patient-reported Outcomes SurveyLauren M Mioton, Gregory A Dumanian, Megan E Fracol, et al.Blood|May 19, 2007
Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccinesNia Tatsis, Julie C Fitzgerald, Arturo Reyes-Sandoval, et al.Infection and Immunity|January 31, 2014
Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodentsLais H Teixeira, Cibele A Tararam, Marcio O Lasaro, et al.Pageof 16